INTRODUCTION
============

Adhesive capsulitis is characterized by spontaneous onset of shoulder pain especially at night and global limitation of both active and passive shoulder motion. In 1945, Neviaser and Neviaser \[[@B1]\] described the gross and histologic pathology in a series of cases and proposed the term \'adhesive capsulitis\' as a more precise descriptor of the findings. Adhesive capsulitis is characterized by a thickened, tight glenohumeral joint capsule with adhesions obliterating the normally patulous axillary fold. The fibrotic capsule adheres to itself and to the anatomic neck of the humerus. Normal shoulder joint volumetric capacity is 28 to 35 mL of injected fluid, whereas in adhesive capsulitis, the joint accepts only 5 to 10 mL \[[@B2]\]. Biopsy of the capsule demonstrates a chronic inflammatory infiltrate, absence of a synovial lining, moderate to extensive subsynovial fibrosis, and perivascular lymphocytic reactions \[[@B1],[@B3]\]. Treatment options documented in the literature include supervised physical rehabilitation, nonsteroidal anti-inflammatory medications, oral corticosteroids, intra-articular corticosteroid injection, ultrasound-guided pulsed-mode radiofrequency lesioning of the suprascapular nerve, botulinum toxin intra-articular injection, distension arthrography, closed manipulation, open surgical release, and arthroscopic capsular release \[[@B4],[@B5],[@B6],[@B7]\]. Glenohumeral joint distension, which was first described in 1965, was performed at the time of surgery and repeated until visualization of capsular rupture \[[@B8]\]. With respect to improving range of motion, hydrodilation has been reported to be superior to manipulation performed in the anesthetized patient \[[@B9]\]. Treatment consisting of repeated hydrodilation plus steroid injection has been found to be more effective than a single hydrodilation in reducing disability and pain \[[@B10]\]. The capsular distension method with corticosteroid injection has a therapeutic effect, via rupture of the stiffened capsule by hydropressure and reduction of synovial inflammation and capsular fibrosis. This method allows for improvement of shoulder motion and pain with a deceased time to funcConclusion Ultrasonography-guided capsular distension by a posterolateral approach has similar effects to fluoroscopy-guided capsular distension by an anterior approach. Keywords Adhesive capsulitis, Injectiontional recovery \[[@B11],[@B12],[@B13]\].

Blind shoulder intra-articular injections, which are widely used in clinical settings, have reported accuracies ranging from 27% to 80%, depending on approaches used. Ultrasonography allows for more precise needle positioning, is less time-consuming, and requires less radiation exposure than fluoroscopy \[[@B14]\].

Magnetic resonance imaging (MRI) has been used for the identification of changes in the appearance of the joint capsule and periarticular tissues (thickening, contrast enhancement, and obliteration of adjacent fat planes) at the rotator interval and joint capsule at the level of the axillary pouch with variable performances. Gondim Teixeira et al. \[[@B14]\] reported sensitivity and specificity values for the MRI signs (inferior glenohumeral ligament T2 hyperintensity, inferior glenohumeral ligament enhancement, subcoracoid fat triangle obliteration, coracohumeral ligament thickness, and rotator interval enhancement) of adhesive capsulitis. The highest specificity among these was 94.10% of rotator interval enhancement. The rotator interval is the triangular space located in the anterosuperior portion of the glenohumeral joint. It is bounded by the supraspinatus superiorly and the subscapularis inferiorly, and the coracoid process forms its medial base. Contained within this triangular space are the coracohumeral ligament, middle glenohumeral ligament, superior glenohumeral ligament, long head of the biceps tendon, and anterior joint capsule \[[@B15]\].

Harryman et al. \[[@B16]\] showed that sectioning of the rotator interval capsule and ligamentous structures increased passive glenohumeral flexion, extension, external rotation, and adduction in 80 shoulders of the first comprehensive cadaveric study. Therefore, we aimed to evaluate the clinical effect of fluoroscopy-guided capsular distension by an anterior approach compared with ultrasonography-guided capsular distension from a posterolateral approach. It was the hypothesis of this study that capsular distension by an anterior approach would have a better effect compared to capsular distension by a posterolateral approach.

MATERIALS AND METHODS
=====================

Participants
------------

From May 2011 to December 2012, 79 participants with shoulder pain and motion limitations who visited the Department of Rehabilitation Medicine of our hospital were enrolled. Fifteen participants were excluded because they did not meet criteria or declined to participate. Of the remaining 64 participants were assigned into one of two groups (group A, fluoroscopy-guided capsular distension with anterior approach; group B, ultrasonography-guided capsular distension with posterior approach). The allocation sequence was generated using a computer program (Microsoft Excel) simple randomization method. Except for 10 participants with follow-up loss, 54 participants were analyzed ([Fig. 1](#F1){ref-type="fig"}). The exclusion criteria were shoulder surgery history and systemic disease that could affect shoulder arthritis. Even though included participants had received shoulder treatment for at least three months, they suffered from shoulder pain and global motion limitations, especially internal rotation and adduction direction. Age, gender, symptom duration, and symptom side were recorded.

Methods
-------

### Fluoroscopy-guided capsular distension method (group A)

The procedure was performed in the operating room. Participants were monitored by pulse oximeter and noninvasive manometer. The participants were put in a supine position with an adjusted Fluorostar 7900 C-arm (GE Healthcare, Wendelstein, Germany) ([Fig. 2A](#F2){ref-type="fig"}). After aseptic preparation, a 23-gauge spinal needle was placed in the middle third of the glenohumeral joint. Needle placement was confirmed with a glenohumeral arthrogram after injection of 1 mL of nonionic radiopaque contrast material ([Fig. 2B](#F2){ref-type="fig"}). After confirmation, 2% lidocaine (5 mL), contrast dye (5 mL), triamcinolone (40 mg), and normal saline (9 mL), in a total fluid volume of 20 mL, were injected under fluoroscopic imaging ([Fig. 2C](#F2){ref-type="fig"}).

### Ultrasonography-guided capsular distension method (group B)

The participants were put in a sitting position in a chair with the affected shoulder adducted and internally rotated and the elbow flexed to grasp the contralateral shoulder. After aseptic preparation, the joint injection was performed using a posterolateral approach with a 23-gauge needle under LOGIQ P5 ultrasound guidance (GE Healthcare) ([Fig. 3A](#F3){ref-type="fig"}). After needle placement confirmation ([Fig. 3B](#F3){ref-type="fig"}), 2% lidocaine (5 mL), triamcinolone (40 mg), and normal saline (14 mL), for a total 20 mL fluid volume, were injected under sono-guidance ([Fig. 3C](#F3){ref-type="fig"}).

### Physical therapy

After injection, all patients received physiotherapy four times in the first week and then two times a week thereafter for eight weeks. The program was composed of physical modalities (heat and electrical therapy) and therapeutic exercise (gentle PROM exercise, active assisted ROM exercise, active ROM exercise, stretching exercise, and wand exercise, etc.).

### Outcome measures

Treatment effects were assessed using the shoulder pain and disability index (SPADI), the visual numeric scale (VNS), passive range of motion (PROM) of the shoulder (flexion, abduction, and external rotation), hand grip, and pinch power at 4 times: baseline and at one week, five and nine weeks after injection.

### Shoulder pain and disability index

This index is a measure of functional disability with a score from 0 (best) to 10 (worst) and was applied to eight categories in the present study: hair washing, washing of the back, putting on an undershirt or jumper, putting on a shirt that buttons down the front, putting on pants, placing an object on a high shelf, carrying a heavy 10 pound object, and removing something from a back pocket.

### Visual numeric scale

The factor is a measure of shoulder pain, scored from 0 (no pain) to 10 (the worst pain imaginable).

### Passive range of motion of shoulder

This variable measures shoulder motion ability with passive movement using a conventional goniometer. The measurement included abduction in the frontal plane, forward flexion, and external rotation with the arm at 0° abduction.

### Hand grip and pinch power

These variables are used to measure upper extremity power improvement. Grip strength was tested, followed by a key (lateral) pinch test. The participants held the Saehan Hydraulic Hand Dynamometer (Saehan, Masan, Korea) in the hand to be tested with their shoulder adducted and neutrally rotated, elbow flexed at 90° and forearm in a neutral position. The handle of the dynamometer was adjusted until the base rested on the first metacarpal (heel of palm) and the handle rested in the middle of the four fingers. Participants squeezed the dynamometer with maximum isometric effort, which was maintained for about five seconds. No other body movement was allowed. The participants were strongly encouraged to give their maximum effort. The participants then held the pinch groove of JAMAR Hydraulic Pinch Gauge (Sammons Preston Rolyan, Nottinghamshire, UK) with the thumb pad and lateral aspect of the middle phalanx of the index finger. Participants pinched the gauge with maximum isometric effort. The pinch gauge was held at the distal end by the examiner to prevent dropping.

### Statistics

Statistical data were analyzed with the SPSS software ver. 18 (SPSS Inc., Chicago, IL, USA). We investigated the difference in improvement of SPADI, VNS, PROM, and hand power between the two groups by a two-way repeated measures analysis of variance (ANOVA) with Bonferroni correction as the post-hoc test. The significance level was defined as a p-value less than 0.05.

RESULTS
=======

The general characteristics of 54 participants are shown in [Table 1](#T1){ref-type="table"}. The mean SPADI scores in groups A and B were 37.37±17.36 and 36.00±16.84 (at baseline), 24.48±11.37 and 18.41±13.51 (at one week), 15.48±11.22 and 14.41±13.90 (at five weeks), and 12.89±10.62 and 12.93±13.75 (at nine weeks), respectively. The SPADI scores improved one week after injection and continued to improve until nine weeks in both groups (p\<0.05). However, no statistical differences in changes of SPADI scores between the two groups were identified (p\>0.05) ([Fig. 4](#F4){ref-type="fig"}). The mean VNS scores in groups A and B were 6.48±18.82 and 6.30±1.38 (at baseline), 3.63±1.90 and 2.81±1.81 (at one week), 1.93±1.43 and 2.15±1.89 (at five weeks), and 1.48±1.28 and 1.81±1.84 (at nine weeks), respectively. The VNS scores improved one week after injection and continued to improve until nine weeks in the two groups (p\<0.05). However, no statistical differences in changes of VNS scores between the two groups were seen (p\>0.05) ([Fig. 5](#F5){ref-type="fig"}).

PROM of the shoulder showed improvement one week after injection and continued to improve up until nine weeks in two groups (p\<0.05). However, no statistical differences in changes of PROM were found between groups A and B ([Table 2](#T2){ref-type="table"}). The mean hand grip power scores in groups A and B were 21.59±11.60 and 22.15±10.00 kg (at baseline), 24.11±11.28 and 24.57±8.98 kg (at one week), 24.61±10.68 and 24.81±8.91 kg (at five weeks), and 25.13±11.11 and 25.44±9.20 kg (at nine weeks), respectively. Hand grip power showed improvement one week after injection and continued to improve until nine weeks in both groups (p\<0.05). However, no statistical differences in changes of hand grip power were found between the two groups (p\>0.05) ([Fig. 6](#F6){ref-type="fig"}). The mean hand pinch power in groups A and B were 6.81±2.60 and 6.33±2.13 kg (at baseline), 7.48±2.49 and 7.17±1.91 kg (at one week), 7.69±2.57 and 7.28±1.91 kg (at five weeks), and 7.81±2.53 and 7.37±1.95 kg (at nine weeks), respectively. Hand pinch power showed improvement one week after injection and continued to improve until nine weeks in the two groups (p\<0.05). However, no statistical differences in changes of hand pinch power were found between groups A and B (p\>0.05) ([Fig. 7](#F7){ref-type="fig"}).

DISCUSSION
==========

Adhesive capsulitis has been described as having three sequential phases: a painful stage, a freezing stage, and a thawing or recovery stage. However, there is no evidence to validate this classification, and its clinical utility is questionable. Pain and a limited ROM can occur in all phases of adhesive capsulitis, which often does not follow a stepwise course. In this condition, pain and decreased ROM can persist for one to two years, and up to 10% of patients never recover a full ROM \[[@B17]\]. It is important for physicians to decide which treatment is effective and timely as well as appropriate for patients with adhesive capsulitis.

Marx et al. \[[@B3]\] proposed that steroid injections provide chemical ablation of the synovitis, thus limiting the subsequent development of fibrosis and shortening the natural history of the disease. Tveita et al. \[[@B13]\] reported that the patients treated with distension plus steroids showed significant improvement in various ROM measures and experienced pain reduction compared with the group treated with steroids alone. Capsular distension is thought to exert its positive effects by improving glenohumeral mobility via stretching or rupturing of the joint capsule.

Park et al. \[[@B18]\] reported that ultrasonography-guided capsular distension using a posterolateral approach had comparable effects with fluoroscopy-guided capsular distension with a posterior approach for treatment of adhesive capsulitis of the shoulder and can be substituted for fluoroscopic capsular distension, which is advantageous from the viewpoint of radiation hazard mitigation, time, cost-effectiveness, and convenience. However, the rotator interval, a triangular anatomic area in the anterosuperior aspect of the shoulder, was taken into account as an important part of the pathology in adhesive capsulitis \[[@B19]\]. For this reason, we expected that an anterior approach to capsular distension would have better efficacy compared with a posterior approach. But the result of this study showed no difference between the treatments. Compared with capsular distension using a posterolateral approach, the anterior approach showed no better improvement of PROM. After capsular distension, the degree of improvement in the ROM is an important factor that can be used to evaluate the effectiveness of the treatment. Limitation of motion in patients with adhesive capsulitis is prominent in external rotation followed by abduction, internal rotation and flexion \[[@B20]\]. Levine et al. \[[@B21]\] reported that patients who were initially evaluated to have more limited ROM, especially for forward flexion and external rotation of their shoulders, were more likely to require surgical treatment. After capsular distension, Park and Hwang \[[@B22]\] found that forward flexion and internal rotation were improved significantly, while Choi et al. \[[@B23]\] reported that forward flexion, abduction and external rotation experienced the same positive results. Kim et al. \[[@B24]\] reported that forward flexion and abduction also significantly improved. We found that forward flexion, abduction and external rotation showed significant improvement in both treatment groups with no statistically significant difference. Because internal rotation range was initially normal in the most participants, we didn\'t compare these results.

The positive results were attributed by the pathology of the anterior capsule of adhesive capsulitis. But the results of anterior approach study were no different than those of posterior approach.

Shoulder pain, range of movement, and disability have been the most commonly used endpoints in clinical trials for shoulder disorders. Chronic muscle pain is associated with abnormal patterns of muscular activity, resulting in altered movement strategies. Many patients with adhesive capsulitis complained of hand weakness. Dupeyron et al. \[[@B25]\] reported that pain, ROM, function, and strength are important components for evaluating shoulder disorders. Staples et al. \[[@B26]\] discovered that the SPADI and disabilities of the arm, shoulder and hand (DASH) have acceptable construct validity for patients with adhesive capsulitis. In this study, we measured eight disability categories of SPADI and hand grip and pinch power instead of using the DASH questionnaire for the evaluation of functional disability. There were no statistically significant differences between the treatment groups. We tried to know about how adhesive capsulitis affect upper extremity strength, it was different from other studies. A limitation of this study was that we used two different imaging guidance methods, even though they showed similar efficacy in previous studies.

We expected an anterior approach to capsular distension to be better than a posterolateral approach because the rotator interval was considered an important component of the pathology in adhesive capsulitis. However, ultrasonography-guided capsular distension by a posterolateral approach had outcomes similar to fluoroscopy-guided capsular distension using an anterior approach.
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![Patient flowchart.](arm-38-360-g001){#F1}

![Fluoroscopy-guided capsular distension method. (A) The participants were put in a supine position with a C-arm adjusted in the operating room. (B) Needle placement was confirmed in a glenohumeral arthrogram after injection of 1 mL of nonionic radiopaque contrast material. (C) After confirmation, 2% lidocaine (5 mL), contrast dye (5 mL), triamcinolone (40 mg), and normal saline (9 mL), for a total volume of 20 mL, were injected under fluoroscopic imaging.](arm-38-360-g002){#F2}

![Ultrasonography-guided capsular distension method. (A) The participants were put in a sitting position in a chair, and the affected shoulder was adducted and internally rotated and the elbow flexed to grasp the contralateral shoulder. (B) The joint injection was performed using a posterolateral approach with a 23-gauge needle under sono-guidance. (C) After needle placement confirmation, 2% lidocaine (5 mL), triamcinolone (40 mg), and normal saline (14 mL), for a total volume of 20 mL fluid, were injected under sono-guidance.](arm-38-360-g003){#F3}

![Comparison of shoulder pain and disability index (SPADI) after capsular distension. SPADI was significantly improved in both groups (^\*^p\<0.05). However, no statistically significant difference in the changes of SPADI was found between the two groups.](arm-38-360-g004){#F4}

![Comparison of visual numeric scale (VNS) after capsular distension. VNS was significantly improved in groups A and B (^\*^p\<0.05). However, no statistically significant difference in the VNS changes was found between the two groups.](arm-38-360-g005){#F5}

![Comparison of grip power after capsular distension. Grip power (kg) was significantly improved in the two groups (^\*^p\<0.05). However, no statistically significant difference in the changes of grip power was found between the two groups.](arm-38-360-g006){#F6}

![Comparison of pinch power after capsular distension. Pinch power (kg) was significantly improved in the two groups (^\*^p\<0.05). However, no statistically significant difference in changes of pinch power was found between the two groups.](arm-38-360-g007){#F7}

###### 

Characteristics of the participants
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Values are presented as number (%) or mean±standard deviation.

Group A, fluoroscopy-guided capsular distension; group B, ultrasonography-guided capsular distension.

###### 

Comparison of the PROM after capsular distension
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Values are presented as number (%) or mean±standard deviation.

PROM, passive range of motion; group A, fluoroscopy-guided capsular distension; group B, ultrasonography-guided capsular distension.

^\*^p\<0.05, comparison of before vs. 1 week, 5 and 9 weeks after injection.
